SEC Filing Roivant Sciences Ltd.
4.7 (118) · € 29.00 · En Stock
ROIV -- Is Its Stock Price A Worthy Investment? Learn More.
SEC Filing Roivant Sciences Ltd.
Sumitomo Dainippon Pharma and Roivant Sciences Sign Definitive
Ramaswamy sells $33 million in Roivant stock, plans to use some
Roivant Sciences Ltd. (NASDAQ:ROIV) Q2 2023 Earnings Call Transcript
SPAC SEC filing status as of 9/18/21 - Orange/new, green/meetings
Myovant Provides Corporate Update and Reports Financial Results
Immunovant Shares Climb Following Roivant Sciences' Purchase of
Roivant Sciences (ROIV) Stock Message Board
Roivant Sciences Sells 99,350 Shares as Chief Accounting Officer
SEC Filing Roivant Sciences Ltd.
Assenagon Asset Management S.A. Invests $4.20 Million in Roivant
